Episode 100: Colorectal Cancer Series, Pt. 2 - Adjuvant Therapy in Stage III Colon Cancer The Fellow on Call: The Heme/Onc Podcast
-
- Medicine
This week, we kick off our discussion of adjuvant systemic treatment in colon cancer, beginning with Stage III colon cancer. We will review the evidence basis for adjuvant therapy as well as the two main chemotherapy regimens including duration and side effects.
Content:
- Why do we need adjuvant therapy in stage III colon cancer?
- What is FOLFOX? What is CAPOX? When do we use what?
- What is the optimal duration of therapy?
- What are the characteristics deemed high risk?
- Can we discontinue oxaliplatin early?
- What is the role of oxaliplatin in older patients?
** Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodes
Love what you hear? Tell a friend and leave a review on our podcast streaming platforms!
Twitter: @TheFellowOnCall
Instagram: @TheFellowOnCall
Listen in on: Apple Podcast, Spotify, and Google Podcast
This week, we kick off our discussion of adjuvant systemic treatment in colon cancer, beginning with Stage III colon cancer. We will review the evidence basis for adjuvant therapy as well as the two main chemotherapy regimens including duration and side effects.
Content:
- Why do we need adjuvant therapy in stage III colon cancer?
- What is FOLFOX? What is CAPOX? When do we use what?
- What is the optimal duration of therapy?
- What are the characteristics deemed high risk?
- Can we discontinue oxaliplatin early?
- What is the role of oxaliplatin in older patients?
** Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodes
Love what you hear? Tell a friend and leave a review on our podcast streaming platforms!
Twitter: @TheFellowOnCall
Instagram: @TheFellowOnCall
Listen in on: Apple Podcast, Spotify, and Google Podcast